Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP179228.RADVizVxL-tfCOZuLxCpROowbX64Mu88IaWX0Nw6JiNcg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP179228.RADVizVxL-tfCOZuLxCpROowbX64Mu88IaWX0Nw6JiNcg130_assertion type Assertion NP179228.RADVizVxL-tfCOZuLxCpROowbX64Mu88IaWX0Nw6JiNcg130_head.
- NP179228.RADVizVxL-tfCOZuLxCpROowbX64Mu88IaWX0Nw6JiNcg130_assertion wasGeneratedBy ECO_0000203 NP179228.RADVizVxL-tfCOZuLxCpROowbX64Mu88IaWX0Nw6JiNcg130_provenance.
- NP179228.RADVizVxL-tfCOZuLxCpROowbX64Mu88IaWX0Nw6JiNcg130_assertion wasDerivedFrom befree-20140225 NP179228.RADVizVxL-tfCOZuLxCpROowbX64Mu88IaWX0Nw6JiNcg130_provenance.
- NP179228.RADVizVxL-tfCOZuLxCpROowbX64Mu88IaWX0Nw6JiNcg130_assertion SIO_000772 22193343 NP179228.RADVizVxL-tfCOZuLxCpROowbX64Mu88IaWX0Nw6JiNcg130_provenance.
- NP179228.RADVizVxL-tfCOZuLxCpROowbX64Mu88IaWX0Nw6JiNcg130_assertion evidence source_evidence_literature NP179228.RADVizVxL-tfCOZuLxCpROowbX64Mu88IaWX0Nw6JiNcg130_provenance.
- NP179228.RADVizVxL-tfCOZuLxCpROowbX64Mu88IaWX0Nw6JiNcg130_assertion description "[We found that both viral load and CD4+CD25+FOXP3+ nTreg percentages decreased significantly in patients with chronic hepatitis B virus infection during 1 year course of tenofovir treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP179228.RADVizVxL-tfCOZuLxCpROowbX64Mu88IaWX0Nw6JiNcg130_provenance.